Journal of Clinical and Investigative Surgery (May 2018)

Is adjuvant hysterectomy an option after radio-chemotherapy for locally advanced cervical cancer? A review

  • Cornelia Nitipir ,
  • Cristina Orlov ,
  • Ana-Maria Popa ,
  • Iulian Slavu,
  • Adrian Tulin

DOI
https://doi.org/10.25083/2559.5555/31.913
Journal volume & issue
Vol. 3, no. 1
pp. 9 – 13

Abstract

Read online

Objective. The purpose of this paper is to review the current concepts in the literature regarding the beneficial effects of adjuvant surgery after concurrent radio-chemotherapy for locally advanced cervical cancer. Method. Research of the literature was performed using PubMed databases in order to find articles relevant to the central topic. The PICOS criteria were used to filter the results. The paper was then structured according to the PRISMA guideline. Results. 50 individual papers were analyzed and sorted according to their relevance for the topic. 18 were classified as relevant. There was little agreement as to how beneficial adjuvant hysterectomy is in locally advanced cervical cancer after chemoradiotherapy. Some articles concluded that patients with a total clinical response after initial treatment might have superior progression-free survival and overall survival after surgery. 2 articles underlined the importance of accurate restaging after primary treatment. The lack of benefit for surgery in patients with bulky disease or persistent adenopathies was agreed upon in all cases. Conclusions. The decision for adjuvant hysterectomy with or without lymphadenectomy is a controversial one and has to be personalized and taken in a multidisciplinary team.

Keywords